Healthcare and technology vendor leasing company Creekridge Capital has signed an agreement with specialty medical device company Endocare to provide leasing programs for the company’s minimally invasive cryoablation technology.
The leasing programs enable Endocare to offer physicians efficient and affordable access to its technology that treats prostate cancer, renal, lung, liver tumors and pain management. The program further expands Creekridge Capital’s reach and expertise in the urology market.
Kevin Quilty, senior vice president of sales and marketing for Endocare, said: By offering lease programs, we can better serve our clients with a full-service approach. We believe that this will be useful as we expand our focus across a number of surgical markets.